HIGHLIGHTS
- who: Youssef Ghannam and colleagues from the Radiation Oncology Department, Centre Paul Papin, Institut de Cancu00e9rologie de l`Ouest, Angers, France Radiation Oncology Department, University Hospital, Brest, France have published the research: Radiotherapy of the Primary Disease for Synchronous Metastatic Cancer: A Systematic Review, in the Journal: Cancers 2022, 14, 5929. of /2022/
- what: Of note, the benefits of a lower dose as thoracic consolidation were assessed in a randomized trial focusing on SCLC patients. The SARON trial (NCT02417662) is a randomized phase III trial focusing on patients with oligometastatic EGFR, ALK and ROS1 mutation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.